(Q54566648)

1 June 2018

title

The different expression patterns of interleukin-1 receptor antagonist in systemic lupus erythematosus. (English)

1 reference

1 June 2018

author name string

Tsai LJ

1

1 reference

1 June 2018

Lan JL

2

1 reference

1 June 2018

Lin CY

3

1 reference

1 June 2018

Hsiao SH

4

1 reference

1 June 2018

Tsai LM

5

1 reference

1 June 2018

Tsai JJ

6

1 reference

1 June 2018

publication date

1 December 2006

1 reference

1 June 2018

published in

Tissue Antigens

1 reference

1 June 2018

volume

68

1 reference

1 June 2018

issue

6

1 reference

1 June 2018

page(s)

493-501

1 reference

1 June 2018

Lymphocytotoxic antibodies in SLE: a review of the literature

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-0039.2006.00704.X

The American College of Rheumatology criteria for the classification of systemic lupus erythematosus: strengths, weaknesses, and opportunities for improvement.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-0039.2006.00704.X

The genes of systemic autoimmunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-0039.2006.00704.X

A sequence-based map of the nine genes of the human interleukin-1 cluster

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-0039.2006.00704.X

Purification, cloning, expression and biological characterization of an interleukin-1 receptor antagonist protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-0039.2006.00704.X

IL-1 receptor antagonist (IL-1RA) gene polymorphism in Sjögren's syndrome and rheumatoid arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-0039.2006.00704.X

Genetic control of IL-1beta bioactivity through differential regulation of the IL-1 receptor antagonist

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-0039.2006.00704.X

Systemic lupus erythematosus and genetic variation in the interleukin 1 gene cluster: a population based study in the southeastern United States

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-0039.2006.00704.X

The underlying diseases and follow-up in Taiwanese children screened by urinalysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-0039.2006.00704.X

Interleukin-1 receptor antagonist: role in biology

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-0039.2006.00704.X

Biological role of interleukin 1 receptor antagonist isoforms

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-0039.2006.00704.X

The balance between IL-1 and IL-1Ra in disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-0039.2006.00704.X

Genetic markers for the efficacy of tumour necrosis factor blocking therapy in rheumatoid arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-0039.2006.00704.X

Association of IL-1beta and IL-1 receptor antagonist haplotypes with rate of decline in lung function in smokers

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-0039.2006.00704.X

Interleukin-1 polymorphisms associated with increased risk of gastric cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-0039.2006.00704.X

HLA-B*5801 allele as a genetic marker for severe cutaneous adverse reactions caused by allopurinol

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-0039.2006.00704.X

Intracellular IL-1Ra type 1 inhibits IL-1-induced IL-6 and IL-8 production in Caco-2 intestinal epithelial cells through inhibition of p38 mitogen-activated protein kinase and NF-kappaB pathways

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-0039.2006.00704.X

Eukaryotic mRNA decapping

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-0039.2006.00704.X

Arginine-serine-rich domains bound at splicing enhancers contact the branchpoint to promote prespliceosome assembly

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-0039.2006.00704.X

Molecular cloning of human fibroblast hyaluronic acid-binding protein confirms its identity with P-32, a protein co-purified with splicing factor SF2. Hyaluronic acid-binding protein as P-32 protein, co-purified with splicing factor SF2

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-0039.2006.00704.X

Anti-cytokines: promising tools for diagnosis and immunotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-0039.2006.00704.X

The use of anakinra, an interleukin-1 receptor antagonist, in the treatment of rheumatoid arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-0039.2006.00704.X

Therapeutic strategies to reduce IL-1 activity in treating local and systemic inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-0039.2006.00704.X

Preliminary results of safety and efficacy of the interleukin 1 receptor antagonist anakinra in patients with severe lupus arthritis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-0039.2006.00704.X

Considerations with the use of biological therapy in the treatment of rheumatoid arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-0039.2006.00704.X

10.1111/J.1399-0039.2006.00704.X

21 January 2018

Identifiers

DOI

1 reference

1 June 2018

1 reference

1 June 2018